Preclinical data show selective lethality in MSI-H cells, proteasomal degradation of bound WRN, and robust tumor regressions in multiple MSI-H xenograft and PDX models, with minimal effects in MSS controls [206]. This evidence concerns the gene WRN and neoplasm.